Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Guelph

$17,500.00

The role of the partitioning defective protein 6 (Par6) and phosphatidylinositide 3-kinases (PI3K) signaling axis in transforming growth factor beta tumour suppressor in breast cancer metastasis

FY 2014-15

Summary
The role of the Par6-PI3K signaling axis in TGFbeta tumour suppressor in breast cancer metastasis Metastasis, the dissemination of a tumour to distant sites, causes 90% of deaths by breast cancer. This is due to the inability of metastatic cancer cells to die and stop their activity in response to current treatments. Transforming growth factor beta (TGFbeta) is a protein produced by breast tumours which promote metastasis, but can paradoxically inhibit tumour growth in the early stages of breast cancer development, due in part to its capacity to promote cell death. Knowing how the cancer cell transduces the signal provided by TGFbeta into a cue that trigger its own destruction is important for our understanding of breast cancer biology and might lead to the discovery of more effective ways to kill cancer cells. We have identified two proteins: Par6 and PI3K, which we believe are essential components of a machinery that dictates a cell’s decision to live or die in response to TGFbeta. This research aims to demonstrate that these proteins interact and this is important to trigger TGFbeta-dependent cell death. We also propose to manipulate these proteins in TGFbeta-dependent metastatic breast cancer cells to demonstrate we can “force” these cells to die in response to this growth factor, thus discovering new venues to treat metastatic breast cancer. The final outcome of this research will help discovering new chemotherapeutic agents for TGFbeta-dependent metastatic breast cancer or some other agents that make these tumours more susceptible to the current chemotherapeutic options.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331364
Name
Delroba Alham
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of the partitioning defective protein 6 (Par6) and phosphatidylinositide 3-kinases (PI3K) signaling axis in transforming growth factor beta tumour suppressor in breast cancer metastasis
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Cell Polarity; Epithelial-Mesenchymal Transition In Metastasis; Inducing Appoptosis (Cell Death); Metastasis; Partitioning Defective Protein 6 (Par6); Phosphatidyl-Inositol-3-Kinase (Pi3k); Phsophorylation/ Activation Of Proteins; Polarity Regulator Proteins; Tgfbeta-Dependent Type Of Breast Cancer
Abstract
The role of the Par6-PI3K signaling axis in TGFbeta tumour suppressor in breast cancer metastasis Metastasis, the dissemination of a tumour to distant sites, causes 90% of deaths by breast cancer. This is due to the inability of metastatic cancer cells to die and stop their activity in response to current treatments. Transforming growth factor beta (TGFbeta) is a protein produced by breast tumours which promote metastasis, but can paradoxically inhibit tumour growth in the early stages of breast cancer development, due in part to its capacity to promote cell death. Knowing how the cancer cell transduces the signal provided by TGFbeta into a cue that trigger its own destruction is important for our understanding of breast cancer biology and might lead to the discovery of more effective ways to kill cancer cells. We have identified two proteins: Par6 and PI3K, which we believe are essential components of a machinery that dictates a cell’s decision to live or die in response to TGFbeta. This research aims to demonstrate that these proteins interact and this is important to trigger TGFbeta-dependent cell death. We also propose to manipulate these proteins in TGFbeta-dependent metastatic breast cancer cells to demonstrate we can “force” these cells to die in response to this growth factor, thus discovering new venues to treat metastatic breast cancer. The final outcome of this research will help discovering new chemotherapeutic agents for TGFbeta-dependent metastatic breast cancer or some other agents that make these tumours more susceptible to the current chemotherapeutic options.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Delroba, Alham
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~